Cargando…

Covid-19 and alcohol associated liver disease

The COVID-19 pandemic is having substantial impacts on the health status of individuals with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). AUD and ALD have both been impacted throughout the pandemic, with increases in alcohol use during the early stages of the pandemic, redu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deutsch-Link, Sasha, Curtis, Brenda, Singal, Ashwani K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349236/ https://www.ncbi.nlm.nih.gov/pubmed/35933291 http://dx.doi.org/10.1016/j.dld.2022.07.007

Ejemplares similares

Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation
por: Moon, Andrew M., et al.
Publicado: (2021)

Therapeutic targets in alcohol-associated liver disease: progress and challenges
por: Adekunle, Ayooluwatomiwa Deborah, et al.
Publicado: (2023)

Integrated Multidisciplinary Management of Alcohol-associated Liver Disease
por: Holbeck, Malia, et al.
Publicado: (2023)

Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic
por: Deutsch-Link, Sasha, et al.
Publicado: (2022)

Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target
por: Abdallah, Mohamed A., et al.
Publicado: (2020)

Editorial: Alcohol-associated liver disease—From pathogenesis to treatment
por: Kharbanda, Kusum K., et al.
Publicado: (2022)

Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future
por: Xie, Chencheng, et al.
Publicado: (2023)

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
por: Raff, Evan J., et al.
Publicado: (2015)

Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer
por: Ravi, Sujan, et al.
Publicado: (2014)

PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum
por: Salameh, Habeeb, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Daher, Darine, et al.
Publicado: (2023)

Impact of COVID-19 on Liver Transplant Activity in the USA: Variation by Etiology and Cirrhosis Complications
por: Kuo, Yong-Fang, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Prevalence and Factors Affecting Occurrence of Type 2 Diabetes Mellitus in Saudi Patients with Chronic Liver Disease
por: Singal, Ashwani K., et al.
Publicado: (2008)

Severe Alcoholic Hepatitis: Atypical Presentation with Markedly Elevated Alkaline Phosphatase
por: Axley, Page, et al.
Publicado: (2017)

Impact of COVID-19 on the liver transplant activity in the US: variation by the region, etiology, and cirrhosis complications
por: Singal, Ashwani, et al.
Publicado: (2022)

Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
por: Ravi, Sujan, et al.
Publicado: (2017)

Sending an SOS: Healing the Liver with the Bone Marrow
por: Ayares, Gustavo, et al.
Publicado: (2022)

Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials
por: Marot, Astrid, et al.
Publicado: (2020)

Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications
por: Axley, Page, et al.
Publicado: (2018)

Correction: Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications
por: Axley, Page, et al.
Publicado: (2018)

Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy
por: Xie, Chencheng, et al.
Publicado: (2020)

Management of Hepatorenal Syndrome: A Review
por: Tariq, Raseen, et al.
Publicado: (2020)

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
por: Younossi, Zobair M., et al.
Publicado: (2022)

Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
por: Coni, Pierpaolo, et al.
Publicado: (2021)

Alcoholic foamy degeneration: an unusual presentation of the alcoholic liver disease diagnosed on autopsy
por: Joshi, Rashmi, et al.
Publicado: (2023)

Ethnic Minorities and Low Socioeconomic Status Patients With Chronic Liver Disease Are at Greatest Risk of Being Uninsured
por: Ohikere, Kabiru, et al.
Publicado: (2021)

Advancements in the Alcohol-Associated Liver Disease Model
por: Zhu, Lin, et al.
Publicado: (2022)

The lymphatic system in alcohol-associated liver disease
por: Kondo, Reiichiro, et al.
Publicado: (2020)

Loneliness and Daily Alcohol Consumption During the COVID-19 Pandemic
por: Bragard, Elise, et al.
Publicado: (2021)

Alcohol Use Disorder and Alcohol-Associated Liver Disease
por: Ramkissoon, Resham, et al.
Publicado: (2022)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease
por: Dukić, Marija, et al.
Publicado: (2023)

COVID-19 and liver injury: where do we stand?
por: Papadopoulos, Nikolaos, et al.
Publicado: (2020)

PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease
por: Salameh, Habeeb, et al.
Publicado: (2016)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

Dietary cholesterol in alcohol-associated liver disease
por: Jia, Lin
Publicado: (2023)

From intestinal dysbiosis to alcohol-associated liver disease
por: Mendes, Beatriz Garcia, et al.
Publicado: (2020)

Programmed cell death in alcohol-associated liver disease
por: Miyata, Tatsunori, et al.
Publicado: (2020)

The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes
por: Cotter, Thomas G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hh483cblvlv3gqug4s6gcp1k90